Endocrinology of Pregnancy Practice Questions

Q: Earliest human chorionic gonadotropin (HCG) is detected when?

8-9 days post fertilization. **Explanation:** The correct answer is **8-9 days post fertilization**. Human Chorionic Gonadotropin (hCG) is a glycoprotein hormone secreted by the **syncytiotrophoblast** of the developing blastocyst. 1. **Why it is correct:** Implantation typically occurs between 6 to 10 days after fertilization. Once the blastocyst implants into the decidua, the syncytiotrophoblast begins producing hCG to maintain the corpus luteum. Using sensitive radioimmunoassays (RIA), hCG can be detected in maternal serum as early as **8 to 9 days after fertilization**, which coincides almost exactly with the time of implantation. 2. **Analysis of Incorrect Options:** * **8-10 days after ovulation:** While fertilization usually occurs within 24 hours of ovulation, "post-fertilization" is the more precise embryological milestone used in standard textbooks (like Williams Obstetrics) for the earliest detection. * **3-4 weeks:** By this time, a woman has usually missed her period. hCG is detectable much earlier than this (around the time of the expected period, or 2 weeks post-fertilization, it is easily detected in urine). * **10th day of menstrual cycle:** This is typically pre-ovulatory in a standard 28-day cycle; fertilization has not yet occurred. **High-Yield Clinical Pearls for NEET-PG:** * **Doubling Time:** In early pregnancy, serum hCG levels double every **48 to 72 hours**. * **Peak Levels:** hCG levels reach their peak at **8–10 weeks** of gestation (approx. 100,000 mIU/mL) and then decline to a lower plateau. * **Subunits:** The **beta (β) subunit** is unique to hCG, making it the basis for pregnancy tests (the alpha subunit is identical to LH, FSH, and TSH). * **Discriminatory Zone:** The level of hCG at which a gestational sac should be visible on Transvaginal Sonography (TVS) is **1,500–2,000 mIU/mL**.

Q: All are true about diabetes in pregnancy except?

Neonatal hyperglycemia. In maternal diabetes, the pathophysiology is governed by the **Pedersen Hypothesis**: maternal hyperglycemia leads to fetal hyperglycemia, which triggers fetal pancreatic beta-cell hyperplasia and **hyperinsulinism**. **Explanation of the Correct Answer:** * **D. Neonatal Hyperglycemia:** This is the correct "except" choice because infants of diabetic mothers (IDMs) actually experience **Neonatal Hypoglycemia**. After birth, the high glucose supply from the mother is abruptly cut off, but the neonate’s hyperinsulinemic state persists, causing a rapid drop in blood glucose levels (usually within 1–3 hours of birth). **Explanation of Incorrect Options:** * **A. Macrosomia:** Fetal hyperinsulinism acts as a growth hormone, leading to excessive deposition of fat and glycogen (macrosomia), typically defined as a birth weight >4000g. * **B. IUGR:** While Gestational Diabetes (GDM) causes macrosomia, **Pre-gestational Diabetes** (Type 1 or 2) with long-standing vascular complications (vasculopathy) can lead to placental insufficiency, resulting in growth restriction. * **C. Congenital Anomalies:** These occur due to poor glycemic control during organogenesis (first trimester). The most specific anomaly is **Caudal Regression Syndrome**, though the most common are **Cardiac defects** (e.g., VSD, Transposition of Great Arteries). **NEET-PG High-Yield Pearls:** * **Most common metabolic abnormality in IDM:** Hypoglycemia. * **Other metabolic issues:** Hypocalcemia, Hypomagnesemia, and Hyperbilirubinemia. * **Hematologic:** Polycythemia (due to fetal hypoxia and increased erythropoietin). * **Respiratory:** Delayed pulmonary surfactant synthesis leading to **Respiratory Distress Syndrome (RDS)**. * **Cardiac:** Hypertrophic Cardiomyopathy (specifically asymmetric septal hypertrophy).

Q: Human chorionic gonadotropin (hCG) can be estimated earliest by which method?

Radioimmunoassay. **Explanation:** **Why Radioimmunoassay (RIA) is the correct answer:** Radioimmunoassay is the most sensitive and specific method for detecting human chorionic gonadotropin (hCG). It utilizes the **beta-subunit (β-hCG)** principle, which prevents cross-reactivity with LH, FSH, and TSH. Due to its high sensitivity (detecting levels as low as 5 mIU/mL), it can identify hCG in maternal serum as early as **8 to 9 days after fertilization** (roughly 6 days before the missed period). This makes it the gold standard for the earliest possible detection of pregnancy. **Analysis of Incorrect Options:** * **Enzyme-linked immunosorbent assay (ELISA):** While widely used in modern clinical practice and "Home Pregnancy Tests" (Urine) due to speed and ease, it generally has a higher detection threshold than RIA. It typically becomes positive around the time of the missed period. * **Radioreceptor assay:** This method measures the biological activity of the hormone by its binding capacity to receptors. While sensitive, it cannot distinguish between hCG and LH, leading to lower specificity compared to RIA. * **Bioassay:** These are historical tests (e.g., Aschheim-Zondek, Friedman test) involving animal models. They are time-consuming, expensive, and lack the sensitivity required for early detection. **High-Yield Clinical Pearls for NEET-PG:** * **Doubling Time:** In a healthy intrauterine pregnancy, serum β-hCG levels double every **48 hours** during the first 8 weeks. * **Peak Levels:** hCG levels reach their peak at **8–10 weeks** (approx. 100,000 mIU/mL) and then decline to a plateau. * **Discriminatory Zone:** The level of hCG at which a gestational sac should be visible on TVS is **1500–2000 mIU/mL**. * **Source:** hCG is secreted by the **syncytiotrophoblast** cells of the developing placenta.

Q: What is the threshold of hemoglobin A1c for the diagnosis of diabetes in pregnancy?

6.50%. **Explanation:** The diagnosis of diabetes in pregnancy is categorized into two types: **Overt (Pre-gestational) Diabetes** and **Gestational Diabetes Mellitus (GDM)**. According to the WHO and ADA guidelines, the threshold for diagnosing overt diabetes during the first prenatal visit is an **HbA1c ≥ 6.5%**. 1. **Why 6.5% is correct:** This value is the standardized diagnostic cutoff for diabetes in the non-pregnant population. When a woman presents in early pregnancy with an HbA1c of 6.5% or higher, it indicates that she likely had undiagnosed pre-existing (overt) diabetes prior to conception, rather than GDM, which typically develops in the second half of pregnancy due to placental hormones. 2. **Analysis of Incorrect Options:** * **6% (Option A):** While an HbA1c between 5.7% and 6.4% is considered "prediabetes" in non-pregnant individuals, it is not the diagnostic threshold for diabetes. * **7% (Option C):** This is often the therapeutic *target* for glycemic control in non-pregnant diabetics, but it is too high for a diagnostic threshold. * **7.5% (Option D):** This value has no specific diagnostic significance in the context of pregnancy screening. **High-Yield Clinical Pearls for NEET-PG:** * **DIPSI Guidelines:** In India, the "single-step" 75g Oral Glucose Tolerance Test (OGTT) is preferred. A 2-hour plasma glucose **≥ 140 mg/dL** diagnoses GDM, regardless of the fasting status. * **HbA1c Limitations:** HbA1c is less reliable in the 2nd and 3rd trimesters due to increased red cell turnover. It is primarily used in the **1st trimester** to rule out overt diabetes. * **Fasting Plasma Glucose (FPG):** An FPG **≥ 126 mg/dL** at the first visit also diagnostic of overt diabetes.

Q: Doubling of Beta HCG levels is typically seen in approximately what time frame?

48 hours. **Explanation:** The correct answer is **48 hours**. **1. Why 48 hours is correct:** Human Chorionic Gonadotropin (β-hCG) is produced by the syncytiotrophoblast of the developing placenta. In a healthy, viable intrauterine pregnancy (IUP), β-hCG levels rise exponentially during the first trimester. The "doubling time" is a clinical benchmark used to assess pregnancy viability. In approximately 85% of normal early pregnancies, the β-hCG level increases by at least 66% every 48 hours, with the average doubling time being roughly 1.5 to 2 days. **2. Why the other options are incorrect:** * **24 hours:** While β-hCG rises rapidly, a 100% increase in just 24 hours is faster than the physiological norm and is rarely seen. * **72 to 96 hours:** While the doubling time slows down as pregnancy progresses (specifically after reaching 6,000–10,000 mIU/mL), these timeframes are considered too slow for the initial stages of a healthy IUP. A rise of less than 35% in 48 hours is highly suggestive of an ectopic pregnancy or a non-viable intrauterine gestation (impending miscarriage). **3. High-Yield Clinical Pearls for NEET-PG:** * **Peak Levels:** β-hCG levels peak at **8–10 weeks** of gestation (reaching ~100,000 mIU/mL) and then decline to a lower plateau for the remainder of the pregnancy. * **Discriminatory Zone:** This is the level of β-hCG (usually **1,500–2,000 mIU/mL**) at which a gestational sac should be visible on Transvaginal Sonography (TVS). * **Abnormal Patterns:** * **Slow rise/Plateau:** Suggests Ectopic Pregnancy. * **Rapidly falling:** Suggests Abortion. * **Pathologically high:** Suggests Molar pregnancy, Multiple gestations, or Choriocarcinoma.

Q: Which oral hypoglycemic agent is safely given in pregnancy?

Metformin. **Explanation:** The management of hyperglycemia in pregnancy primarily relies on lifestyle modifications and **Insulin**, which remains the gold standard as it does not cross the placenta. However, among oral hypoglycemic agents (OHAs), **Metformin** is the most widely accepted and safely used option. **1. Why Metformin is Correct:** Metformin (a Biguanide) is category B in pregnancy. While it does cross the placenta, it is not associated with increased rates of major congenital malformations or fetal harm. It is particularly useful in patients with Polycystic Ovary Syndrome (PCOS) to prevent early pregnancy loss and in Gestational Diabetes Mellitus (GDM) when patients are needle-phobic or have compliance issues with insulin. **2. Why Other Options are Incorrect:** * **Sitagliptin (DPP-4 Inhibitor):** There is insufficient human data regarding its safety and efficacy during pregnancy. It is generally avoided. * **Glimepiride (Sulfonylurea):** Most second and third-generation sulfonylureas (except Glyburide/Glibenclamide in specific cases) are avoided due to the risk of prolonged neonatal hypoglycemia and lack of long-term safety data. * **Pioglitazone (Thiazolidinedione):** These are contraindicated as they have shown embryotoxicity in animal studies and can affect fetal bone health. **Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC):** Insulin is the DOC for both GDM and Pregestational Diabetes. * **Metformin & PCOS:** Continuing Metformin in the first trimester for PCOS patients reduces the risk of miscarriage and development of GDM. * **Glibenclamide:** It is the only other OHA sometimes considered, but it is associated with higher rates of macrosomia and neonatal hypoglycemia compared to Insulin. * **Target Blood Sugars:** Fasting <95 mg/dL, 1-hour postprandial <140 mg/dL, and 2-hour postprandial <120 mg/dL.

Q: What is the safest treatment for hyperthyroidism in pregnant women?

Propylthiouracil. **Explanation:** The management of hyperthyroidism during pregnancy requires a careful balance between maternal health and fetal safety. **Propylthiouracil (PTU)** is the drug of choice during the **first trimester** of pregnancy. **1. Why Propylthiouracil (PTU) is correct:** PTU is highly protein-bound and less lipid-soluble compared to other antithyroid drugs. This results in **minimal placental transfer**, significantly reducing the risk of fetal malformations. It is preferred in the first trimester (the period of organogenesis) to avoid the specific teratogenic effects associated with Methimazole. **2. Why the other options are incorrect:** * **Methimazole & Carbimazole:** These are avoided in the first trimester because they cross the placenta more readily and are associated with **Methimazole Embryopathy**, which includes **Aplasia cutis** (congenital skin defects on the scalp), esophageal atresia, and choanal atresia. However, Methimazole is often preferred in the **second and third trimesters** to avoid PTU-induced maternal hepatotoxicity. * **Radioactive Iodine (I-131):** This is **absolutely contraindicated** in pregnancy. It crosses the placenta and can cause permanent destruction of the fetal thyroid gland, leading to congenital hypothyroidism and cretinism. **3. High-Yield Clinical Pearls for NEET-PG:** * **Switching Rule:** Use PTU in the 1st trimester; switch to Methimazole in the 2nd and 3rd trimesters. * **Mechanism of PTU:** It inhibits thyroid peroxidase (TPO) and, uniquely, inhibits the **peripheral conversion of T4 to T3**. * **Side Effect:** PTU carries a Black Box Warning for **severe fulminant hepatic failure**. * **Breastfeeding:** Both PTU and Methimazole are considered safe during breastfeeding at low doses.

Q: In pregnancy, which is the best parameter to be measured in thyroid function tests?

TSH. **Explanation:** The assessment of thyroid function in pregnancy is complex due to physiological changes. **Serum TSH** is the most sensitive and reliable parameter for screening and diagnosing thyroid disorders in pregnancy. **Why TSH is the correct answer:** During pregnancy, high levels of Estrogen increase **Thyroid Binding Globulin (TBG)** levels. Additionally, hCG (which shares an alpha subunit with TSH) directly stimulates the TSH receptors on the thyroid gland. Despite these fluctuations, the pituitary-thyroid axis remains the most sensitive indicator of thyroid status. TSH levels slightly decrease in the first trimester due to hCG stimulation but remain the gold standard for monitoring because it reflects the actual metabolic status of the patient relative to pregnancy-specific reference ranges. **Why other options are incorrect:** * **Total T4 and Total T3 (Options C & D):** These are unreliable because Estrogen increases TBG, which leads to a physiological rise in *total* hormone levels (approx. 1.5 times the non-pregnant state). Therefore, elevated Total T3/T4 does not necessarily indicate hyperthyroidism. * **Free T3 (Option B):** While Free T4 is often used alongside TSH, Free T3 is rarely used as a primary screening tool unless T3-toxicosis is suspected. Free hormone assays can also be technically challenging due to protein binding changes in pregnancy. **High-Yield Clinical Pearls for NEET-PG:** 1. **Trimester-specific TSH ranges:** If lab-specific ranges aren't available, the traditional targets are: 1st Trimester: **0.1–2.5** mIU/L; 2nd Trimester: **0.2–3.0** mIU/L; 3rd Trimester: **0.3–3.0** mIU/L. 2. **hCG Effect:** Peak hCG levels (at 10–12 weeks) correlate with the lowest TSH levels. 3. **Drug of Choice:** **Propylthiouracil (PTU)** is preferred in the 1st trimester (to avoid Methimazole embryopathy), while **Methimazole** is preferred in the 2nd and 3rd trimesters (to avoid PTU-induced hepatotoxicity).

Question 1

Which of the following statements is FALSE regarding the endocrine changes in a normal pregnancy?

Accepted Answer

TSH rises in the first and second trimesters but falls in the third trimester.

Answer

There is a fall in free T4/T3 levels during the third trimester.

Answer

Thyroid-stimulating hormone (TSH) falls in the first and second trimesters but increases in the third trimester.

Answer

There is an increase in Thyroid Binding Globulin (TBG).

Question 2

Earliest human chorionic gonadotropin (HCG) is detected when?

Accepted Answer

8-9 days post fertilization

Answer

8-10 days after ovulation

Answer

3-4 weeks

Answer

10th day of menstrual cycle

Question 3

All are true about diabetes in pregnancy except?

Accepted Answer

Neonatal hyperglycemia

Answer

Macrosomia

Answer

Intrauterine growth restriction (IUGR)

Answer

Congenital anomalies

Question 4

A 30-year-old G3P2 patient presents at 20 weeks gestation with a history of two previous large babies (4.6 kg and 4.8 kg, both delivered via cesarean section). She is suspected of having gestational diabetes and undergoes a glucose challenge test. Following a 50g oral glucose load, her blood sugar level is 206 mg/dL, confirming gestational diabetes. Which of the following is NOT a known complication of gestational diabetes?

Accepted Answer

Congenital malformations in the fetus

Answer

Increased susceptibility to infection

Answer

Fetal hyperglycemia

Answer

Neonatal hypoglycemia

Question 5

Human chorionic gonadotropin (hCG) can be estimated earliest by which method?

Accepted Answer

Radioimmunoassay

Answer

Enzyme-linked immunosorbent assay (ELISA)

Answer

Radioreceptor assay

Answer

Bioassay

Question 6

What is the threshold of hemoglobin A1c for the diagnosis of diabetes in pregnancy?

Accepted Answer

6.50%

Answer

6%

Answer

7%

Answer

7.50%

Question 7

Doubling of Beta HCG levels is typically seen in approximately what time frame?

Accepted Answer

48 hours

Answer

24 hours

Answer

72 hours

Answer

96 hours

Question 8

Which oral hypoglycemic agent is safely given in pregnancy?

Accepted Answer

Metformin

Answer

Sitagliptin

Answer

Glimepride

Answer

Pioglitazone

Question 9

What is the safest treatment for hyperthyroidism in pregnant women?

Accepted Answer

Propylthiouracil

Answer

Radioactive iodine

Answer

Methimazole

Answer

Carbimazole

Question 10

In pregnancy, which is the best parameter to be measured in thyroid function tests?

Accepted Answer

TSH

Answer

Free T3

Answer

T4

Answer

Total T3

Endocrinology of Pregnancy — MCQs

Endocrinology of Pregnancy — MCQs

On this page

Practice by Chapter

Want unlimited practice?